Perkins Capital Management’s Plus Therapeutics PSTV Stock Holding History

Perkins Capital Management’s Portfolio PSTV Stock Details PSTV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1	Closed	-$5K	–	133
2018 Q4	$5K	Hold	1	–	–	﹤0.01%	126
2018 Q3	$10K	Sell	1 -7	-88%	-$88.8K	0.01%	132
2018 Q2	$223K	Sell	8 -3	-27%	-$143K	0.16%	109
2018 Q1	$593K	Hold	11	–	–	0.53%	59
2017 Q4	$644K	Buy	11 +6	+120%	+$420K	0.62%	54
2017 Q3	$335K	Hold	5	–	–	0.35%	71
2017 Q2	$962K	Buy	5 +3	+150%	+$606K	1.07%	28
2017 Q1	$703K	Hold	2	–	–	0.73%	49
2016 Q4	$602K	Hold	2	–	–	0.66%	54
2016 Q3	$790K	Hold	2	–	–	0.79%	44
2016 Q2	$811K	Buy	2 +1	+100%	+$597K	0.93%	41
2016 Q1	$340K	Hold	1	–	–	0.43%	70
2015 Q4	$325K	Buy	+1	New	+$938K	0.35%	76
2015 Q3	–	Hold	0	–	–	–	63
2015 Q2	–	Hold	0	–	–	–	64
2015 Q1	–	Hold	0	–	–	–	20
2014 Q4	–	Hold	0	–	–	–	96
2014 Q3	–	Hold	0	–	–	–	84
2014 Q2	–	Hold	0	–	–	–	22
2014 Q1	–	Hold	0	–	–	–	28
2013 Q4	–	Hold	0	–	–	–	33
2013 Q3	–	Hold	0	–	–	–	21
2013 Q2	–	Hold	0	–	–	–	22

Other funds holding PSTV

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MOS

MGO One Seven Beachwood, Ohio $6.06B AUM 28.9% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Perkins Capital Management's PSTV Position: Q1 2019 in Review

Perkins Capital Management sold out of Plus Therapeutics (PSTV) in Q1 2019, closing a stake of 1 share — an estimated $5K sold.

Perkins Capital Management first reported a position in PSTV in Q4 2015 and held it in 13 quarters. The position peaked at $962K in Q2 2017. 7 funds tracked by Wall St. Rank hold PSTV as of Q1 2019.

Perkins Capital Management reported no remaining Plus Therapeutics position as of Q1 2019 after selling out during the quarter.
Perkins Capital Management sold 1 Plus Therapeutics share in Q1 2019, an estimated $5K.
Perkins Capital Management first reported a position in Plus Therapeutics in Q4 2015 and held it in 13 quarters.
Perkins Capital Management's Plus Therapeutics position peaked at $962K in Q2 2017.
7 funds tracked by Wall St. Rank held Plus Therapeutics as of Q1 2019.

Based on Perkins Capital Management's 13F filing for Q1 2019, filed 22 Apr 2019.